| Dr Peter S Doss, MD | |
|
1500 Saint Georges Ave, Avenel, NJ 07001 | |
| (732) 574-8999 | |
| (732) 574-3488 |
| Full Name | Dr Peter S Doss |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 1500 Saint Georges Ave, Avenel, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609869098 | NPI | - | NPPES |
| 217141 | Other | MA | TUFTS HEALTH PLAN |
| 2236722 | Other | MA | FIRST HEALTH PLAN |
| 5498907 | Other | MA | FIRST HEALTH CCN |
| 30204309 | Medicaid | NH | |
| P00197118 | Other | MA | RAIL ROAD MEDICARE |
| 58321 | Other | MA | HEALTHY START |
| 01Y007135MA01 | Other | NH | NH BLUE SHIELD |
| 3552171 | Other | MA | AETNA/US HEALTHCARE |
| 4904825 | Other | MA | CIGNA |
| 2015374 | Medicaid | MA | |
| 90529 | Other | MA | FALLON |
| J26516 | Other | MA | BLUE CROSS/BLUE SHIELD |
| 58231 | Other | MA | CHILDRENS MEDICAL PLAN |
| 973009 | Other | MA | NETWORK HEALTH PLAN |
| AA17288 | Other | MA | HARVARD PILGRIM HEALTH CA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayshore Medical Center | Holmdel, NJ | Hospital |
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Riverview Medical Center | Red bank, NJ | Hospital |
| Jfk Medical Center | Edison, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Coastal Imaging Llc | 8123312055 | 47 |
| Health Village Imaging Llc | 9537263223 | 23 |
| The New Jersey Imaging Network, Llc | 2860633492 | 64 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
| Entity Name | Avenel Iselin Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487674867 PECOS PAC ID: 5597751941 Enrollment ID: O20040422000098 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
| Entity Name | Health Village Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194810978 PECOS PAC ID: 9537263223 Enrollment ID: O20070406000359 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
| Entity Name | The New Jersey Imaging Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629327887 PECOS PAC ID: 2860633492 Enrollment ID: O20130724000791 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
| Entity Name | Coastal Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710334727 PECOS PAC ID: 8123312055 Enrollment ID: O20160816000083 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter S Doss, MD 1500 Saint Georges Ave, Avenel, NJ 07001 Ph: (732) 574-8999 | Dr Peter S Doss, MD 1500 Saint Georges Ave, Avenel, NJ 07001 Ph: (732) 574-8999 |
News Archive
Moberg Derma AB has successfully completed the recruitment of 237 patients with nail fungus (onychomycosis) to participate in the ongoing MOB-015 phase II study.
Extreme Networks, Inc. today introduced the Information Governance Engine, an optional add-on to the ExtremeManagement™ product portfolio, enabling CISOs and CIOs to establish and maintain a clinical baseline that demonstrates compliance with HIPAA and PCI standards for their mission-critical networks. The Information Governance Engine provides an automated scored assessment that empowers IT to understand how network changes may impact compliance.
Americans told lawmakers in Washington that they wanted reforms that would lower costs; Democrats in Congress increased them. They said they wanted Medicare protected; Democrat leaders used it as a piggy bank, cutting hundreds of billions of dollars from Medicare to help pay for this massive new government expansion of health care (Sen. Mitch McConnell, 8/26).
Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.
› Verified 7 days ago
Edward S Rittweger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Leo J Fontana, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
David G Wirtshafter, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Mark Singer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Charles A Saniewski, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 | |
Robert Bashkim Limani, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1500 Saint Georges Ave, Avenel, NJ 07001 Phone: 732-381-8686 Fax: 732-499-7724 |